Nj\u00eb tjet\u00ebr prov\u00eb shpres\u00eb-dh\u00ebn\u00ebse ka filluar p\u00ebr nj\u00eb vaksin\u00eb kund\u00ebr koronavirusit. Nj\u00eb bashk\u00ebpunim mes dy kompanish — nj\u00ebra amerikane dhe tjetra gjermane filloi jav\u00ebn a kaluar n\u00eb Shtetet e Bashkuara. Disa pjes\u00ebmarr\u00ebs jan\u00eb student\u00eb t\u00eb mjek\u00ebsis\u00eb. N\u00eb mbar\u00eb bot\u00ebn disa prova jan\u00eb n\u00eb proces e sip\u00ebr p\u00ebr t\u00eb gjetur nj\u00eb vaksin\u00eb kund\u00ebr COVID-19. Korrespondentja e Z\u00ebrit t\u00eb Amerik\u00ebs Carolyn Presutti ka p\u00ebrgatitur materialin:<\/p>\n
Michael Sikorski po merr pjes\u00eb n\u00eb prova historike. Ai \u00ebsht\u00eb studenti i 17-t\u00eb i mjek\u00ebsis\u00eb q\u00eb injektohet me vaksin\u00ebn kandidate p\u00ebr parandalimin e COVID-19.<\/p>\n
\u201cNdjej nj\u00eb sens p\u00ebrgjegj\u00ebsie, detyrimi: jam i ri, i sh\u00ebndetsh\u00ebm dhe mund t\u00eb marr pjes\u00eb n\u00eb k\u00ebto prova p\u00ebr vaksin\u00eb,\u201d thot\u00eb ai.<\/p>\n
Sikorski dhe 360 t\u00eb tjer\u00eb po marrin pjes\u00eb n\u00eb faz\u00ebn e par\u00eb t\u00eb provave p\u00ebr vaksin\u00eb q\u00eb po zhvillon kompania Pfizer dhe partneri i saj gjerman, BioNTech.<\/p>\n
Kompania po teston paralelisht kat\u00ebr vaksina, me nj\u00eb metod\u00eb t\u00eb njohur si mRNA. Vaksina fut n\u00eb trup nj\u00eb sekuenc\u00eb t\u00eb vog\u00ebl gjenetike t\u00eb virusit, t\u00eb cil\u00ebn organizmi e trajton si protein\u00eb t\u00eb huaj dhe krijon ndaj saj imunitet.<\/p>\n
\u201cTani trupi \u00ebsht\u00eb gati, ka krijuar memorje gjenetike. Kur organizmi has n\u00eb virusin e v\u00ebrtet\u00eb q\u00eb mund ta infektoj\u00eb, p\u00ebrgjigjet me shpejt\u00ebsi dhe e pengon,\u201d thot\u00eb hulumtuesi Mikael Dolsten.<\/p>\n
Sfida kryesore p\u00ebr Pfizer \u00ebsht\u00eb t\u00eb zgjas\u00eb jet\u00ebn e antitrupave n\u00eb qeliz\u00eb.<\/p>\n
Shum\u00eb kompani farmaceutike po p\u00ebrpiqen t\u00eb fitojn\u00eb gar\u00ebn p\u00ebr t\u00eb zhvilluar vaksin\u00ebn kund\u00ebr koronavirusit.<\/p>\n
Firma amerikane, Moderna, si dhe Institutet Komb\u00ebtare t\u00eb Sh\u00ebndetit, po p\u00ebrdorin metod\u00ebn mRNA n\u00eb prova q\u00eb filluan muajin e kaluar. Inovio ka filluar provat q\u00eb mb\u00ebshteten tek metoda me ADN.<\/p>\n
BioNTech\/Pfizer filluan provat m\u00eb 5 maj, nd\u00ebrsa kompania kineze CanSino Biologics \u00ebsht\u00eb para t\u00eb tjerave, pasi ka kaluar n\u00eb faz\u00ebn e dyt\u00eb t\u00eb provave. Universiteti i Oksfordit n\u00eb Angli filloi prova muajin e kaluar. Hulumtuesit n\u00eb Wuhan dhe Pekin po p\u00ebrdorin metod\u00ebn tradicionale t\u00eb provave, duke injektuar vullnetar\u00ebt me viruse joaktive.<\/p>\n
Eksperti kryesor amerikan p\u00ebr s\u00ebmundjet ngjit\u00ebse parashikon se bota do t\u00eb ket\u00eb nj\u00eb vaksin\u00eb efektive brenda muajit tetor:<\/p>\n
\u201cM\u00eb pas vjen sfida p\u00ebr ta prodhuar n\u00eb mas\u00eb q\u00eb t\u00eb arrijm\u00eb ta d\u00ebrgojm\u00eb kudo q\u00eb nevojitet,\u201d thot\u00eb Dr. Anthony Fauci.<\/p>\n
Nd\u00ebrkaq, pjes\u00ebmarr\u00ebs si Sikorski jan\u00eb tani n\u00ebn mbikqyrje p\u00ebr t\u00eb garantuar se vaksina nuk ka pasoja an\u00ebsore:<\/p>\n
\u201cN\u00eb ora 9, \u00e7do nat\u00eb, bie zilja e celularit dhe m\u00eb kujton q\u00eb t\u00eb mbush ditarin e p\u00ebrditsh\u00ebm mbi gjendjen sh\u00ebndet\u00ebsore. Mas temperatur\u00ebn me termometrin q\u00eb m\u00eb kan\u00eb dh\u00ebn\u00eb. U p\u00ebrgjigjem pyetjeve t\u00eb formularit, p\u00ebr shembull n\u00ebse kam dhimbje muskujsh, temperatur\u00eb, enjtje ky\u00e7esh,\u201d thot\u00eb student Michael Sikorski.<\/p>\n
N\u00ebse \u00e7do gj\u00eb shkon mir\u00eb, pritet q\u00eb vaksina t\u00eb jet\u00eb n\u00eb qarkullim n\u00eb fund t\u00eb vitit, nj\u00eb arritje e pashoqe p\u00ebr nga shpejt\u00ebsia e reagimit p\u00ebr t\u00eb imunizuar popullat\u00ebn kund\u00ebr nj\u00eb s\u00ebmundjeje.\/VOA<\/p>\n","protected":false},"excerpt":{"rendered":"
Nj\u00eb tjet\u00ebr prov\u00eb shpres\u00eb-dh\u00ebn\u00ebse ka filluar p\u00ebr nj\u00eb vaksin\u00eb kund\u00ebr koronavirusit. Nj\u00eb bashk\u00ebpunim mes dy kompanish — nj\u00ebra amerikane dhe tjetra gjermane filloi jav\u00ebn a kaluar n\u00eb Shtetet e Bashkuara. Disa pjes\u00ebmarr\u00ebs jan\u00eb student\u00eb t\u00eb mjek\u00ebsis\u00eb. N\u00eb mbar\u00eb bot\u00ebn disa prova jan\u00eb n\u00eb proces e sip\u00ebr p\u00ebr t\u00eb gjetur nj\u00eb vaksin\u00eb kund\u00ebr COVID-19. Korrespondentja e […]<\/p>\n","protected":false},"author":1,"featured_media":21917,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"footnotes":""},"categories":[6,3,20,21],"tags":[],"yoast_head":"\n